Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis

Published:2018-11-30 Issue:4 Volume:16 Page:361-375
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Park Seon-Cheol¹,Choi Mi Young²,Choi Jina²,Park Eunjung²,Tchoe Ha Jin²,Suh Jae Kyung²,Kim Young Hoon³,Won Seung Hee⁴,Chung Young-Chul⁵,Bae Kyung-Yeol⁶,Lee Sang-Kyu⁷,Park Chan Mi²,Lee Seung-Hwan⁸^ORCID

Affiliation:

1. Department of Psychiatry, Haeundae Paik Hospital, Inje University College of Medicine Busan, Korea

2. National Evidence-based Healthcare Collaborating Agency, Seoul, Korea

3. Department of Psychiatry, Gongju National Hospital, Gongju, Korea

4. Department of Psychiatry, School of Medicine, Kyungpook National University, Daegu, Korea

5. Department of Psychiatry, Chonbuk National University Hospital, Jeonju, Korea

6. Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea

7. Department of Psychiatry, Hallym University Chuncheon Sacred Hospital, Hallym University College of Medicine, Chuncheon, Korea

8. Department of Psychiatry, Inje University Ilsan Paik Hospital, Goyang, Korea

Funder

National Evidence-based Healthcare Collaborating Agency(NECA)

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2018/016/cpn016-04-01.pdf

Reference73 articles.

1. Grand challenges in global mental health

2. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia

3. Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders

4. Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies

5. Corrigan, PW, Liberman, RP, and Engel, JD (1990). From noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry. 41, 1203-1211.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders;Journal of Child and Adolescent Psychopharmacology;2024-08-26

2. Mechanisms of adverse mammary effect induced by olanzapine and therapeutic interventions in rat model.;Toxicology and Applied Pharmacology;2024-04

3. Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia;European Psychiatry;2024

4. Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study;Drugs - Real World Outcomes;2023-12-21

5. Comparison of health resource usage and costs associated with first-generation and second-generation long-acting injectable antipsychotics for patients with schizophrenia: A nationwide population-based cohort study;Asian Journal of Psychiatry;2023-11